The objective of this proof-of-concept study to evaluate mazdutide in participants with alcohol use disorder (AUD). For any individual participant, the maximum duration of study participation is approximately 36 weeks, including screening and posttreatment follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Enrollment
308
Headlands Research - Scottsdale
Behaviors Associated with Alcohol Use Disorder (AUD) as Assessed by the Timeline Followback Method
Time frame: Baseline, Week 28
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Scottsdale, Arizona, United States
Woodland Resarch Northwest/ERG
Rogers, Arkansas, United States
Ark Clinical Research - Fountain Valley
Fountain Valley, California, United States
Synergy San Diego
Lemon Grove, California, United States
Headlands Research-Artemis San Diego
San Diego, California, United States
Research Centers of America ( Hollywood )
Hollywood, Florida, United States
K2 Medical Research - Maitland
Maitland, Florida, United States
K2 Medical Research
Maitland, Florida, United States
Clinical Neuroscience Solutions Inc
Orlando, Florida, United States
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
...and 15 more locations